You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

abi

Showing 26 - 50 of 1,227
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Withdrawn
  • Anatomic Stage III Breast Cancer AJCC v8
  • +11 more
  • (no location specified)
Jan 5, 2023

Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

Not yet recruiting
  • Solid Tumor, Adult
  • +4 more
  • (no location specified)
Apr 24, 2023

Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)

Not yet recruiting
  • Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Apr 16, 2023

Acquired Brain Injury, Disorders of Consciousness Trial in Baltimore (tDCS)

Recruiting
  • Acquired Brain Injury
  • Disorders of Consciousness
  • tDCS
  • Baltimore, Maryland
    Kennedy Krieger Institute
Mar 14, 2022

Cancer of Pancreas Trial in Dallas (Bemcentinib, Nab-paclitaxel, Gemcitabine)

Terminated
  • Cancer of Pancreas
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Sep 26, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +5 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Non-muscle Invasive Bladder Cancer (NMIBC) Trial in New York, Nashville (ABI-009, Gemcitabine)

Completed
Has Results
  • Non-muscle Invasive Bladder Cancer (NMIBC)
  • New York, New York
  • +1 more
May 12, 2021

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Breast Cancer Trial in United States (Gemcitabine, Epirubicin, Albumin-bound Paclitaxel)

Completed
Has Results
  • Breast Cancer
  • Fort Myers, Florida
  • +12 more
Nov 22, 2021

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +3 more
  • (no location specified)
Jun 28, 2022

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial (drug, procedure,

Not yet recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +3 more
  • (no location specified)
Oct 21, 2023

Melanoma Trial in Houston (ABI-007, Ipilimumab, Phone Call)

Completed
Has Results
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 12, 2022

Upper Extremity Dysfunction, Traumatic Brain Injury Trial in West Orange (Active High-definition Transcranial Direct Current

Recruiting
  • Upper Extremity Dysfunction
  • Traumatic Brain Injury
  • Active High-definition Transcranial Direct Current Stimulation (HD-tDCS)
  • MusicGlove
  • West Orange, New Jersey
    Kessler Foundation
Apr 6, 2022

Castration-resistant Prostate Cancer Trial in Wuxi (Polaprezinc, Abiraterone)

Enrolling by invitation
  • Castration-resistant Prostate Cancer
  • Wuxi, Jiangsu, China
    Jiangnan University
Sep 18, 2022

Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Atlanta, Georgia
  • +2 more
Feb 28, 2022

Critical Limb Ischemia Trial in Stanford (Flowmet-D, ABI)

Enrolling by invitation
  • Critical Limb Ischemia
  • Flowmet-D
  • ABI
  • Stanford, California
    Stanford Hospital
Jul 7, 2022

Pancreas Cancer Trial in Houston (Gemcitabine, Nab paclitaxel, IM156)

Not yet recruiting
  • Pancreas Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Aug 15, 2022

Chronic Hepatitis B Trial in Auckland (ABI-H3733 Liquid Oral Dosage Form, ABI-H3733 Solid Oral Dosage Form, Placebo to ABI-H3733

Completed
  • Chronic Hepatitis B
  • ABI-H3733 Liquid Oral Dosage Form
  • +3 more
  • Auckland, New Zealand
    Auckland Clinical Studies
Jan 26, 2021

Breast Cancer Trial in Houston (Panitumumab, Nab-paclitaxel, Carboplatin)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 20, 2022

Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,

Suspended
  • Distal Bile Duct Adenocarcinoma
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Chronic Hepatitis B Trial in Worldwide (ABI-H0731, SOC NrtI)

Terminated
  • Chronic Hepatitis B
  • Beverly Hills, California
  • +23 more
Mar 22, 2022

Resectable Pancreatic Carcinoma, Stage I Pancreatic Cancer AJCC v6 and v7, Stage IA Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Resectable Pancreatic Carcinoma
  • +6 more
  • Gemcitabine Hydrochloride
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 16, 2022

Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +4 more
  • Newport Beach, California
  • +2 more
Aug 16, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Biopsy
  • +8 more
  • (no location specified)
Jan 13, 2023

Neuroendocrine Tumors Trial in New Orleans (ABI-009)

Terminated
Has Results
  • Neuroendocrine Tumors
  • New Orleans, Louisiana
    Ochsner Clinic Foundation
May 17, 2021